Disease Severity and Healthcare Costs Associated With Chronic Kidney Disease in Patients With Systemic Lupus Erythematosus
08:00am - 08:00am EDT - March 19, 2022
08:00am - 08:00am EDT - March 19, 2022
Author(s):
- Shirley P. Huang, GlaxoSmithKline, Research Triangle Park, NC, USA
- Amy Guisinger, GlaxoSmithKline, US Value, Evidence and Outcomes, Research Triangle Park, NC, USA
- Carlyne Averell, GlaxoSmithKline, Research Triangle Park, NC, USA
- Christopher F. Bell, GlaxoSmithKline, Research Triangle Park, NC, USA
| Display Label | Action |
|---|---|
| RNL22P1 - Disease Severity and Healthcare Costs Associated With Chronic Kidney Disease in Patients With Systemic Lupus Erythematosus | Download MP3 |
| RNL22P1 - Disease Severity and Healthcare Costs Associated With Chronic Kidney Disease in Patients With Systemic Lupus Erythematosus | Download Handout |